Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.47 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22814872 | 1.00 | L3MBTL1 (0.51) | L3MBTL1GAATYRMAPTLGALS3 | |
| SCHEMBL1296747 | 0.98 | L3MBTL1 (0.49) | L3MBTL1GAATYRMAPTLGALS3 | |
| SCHEMBL24004015 | 0.83 | LGALS8 (0.58) | TYRLGALS3LGALS8MEN1KMT2A | |
| SCHEMBL5081689 | 0.82 | MEN1 (0.57) | L3MBTL1GAATYRMAPTLGALS3 | |
| SCHEMBL20063941 | 0.82 | MEN1 (0.57) | L3MBTL1GAATYRMAPTLGALS3 | |
| Trehalose SCHEMBL732715 | 0.82 | MEN1 (0.57) | L3MBTL1GAATYRMAPTLGALS3 | |
| Trehalose SCHEMBL4257808 | 0.82 | MEN1 (0.57) | L3MBTL1GAATYRMAPTLGALS3 | |
| Trehalose SCHEMBL23029503 | 0.82 | MEN1 (0.57) | L3MBTL1GAATYRMAPTLGALS3 | |
| Trehalose SCHEMBL25304700 | 0.82 | MEN1 (0.57) | L3MBTL1GAATYRMAPTLGALS3 | |
| SCHEMBL5357747 | 0.82 | MEN1 (0.57) | L3MBTL1GAATYRMAPTLGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023170311-A1 | ANTI-AGING COMPOSITIONS | PROGELIFE (FR) | 2023-09-14 | — | — | WO | disclosed |
| US-9932580-B2 | Compositions and methods for modulating HBV expression | IONIS PHARMACEUTICALS, INC. (US) | 2018-04-03 | — | — | US | disclosed |